Back
Syndax Pharmaceuticals Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
30
SNDX
Syndax Pharmaceuticals
Last Price:
$12.85
Seasonality Move:
15.76%
Sell
44
VRTX
Vertex Pharmaceuticals
Last Price:
$396.54
Seasonality Move:
6.89%
Sell
30
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
-
The current Syndax Pharmaceuticals [SNDX] share price is $13.24. The Score for SNDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
SNDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals [VRTX] share price is $447.50. The Score for VRTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $13.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $447.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
SNDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.15 | Sell |
Relative Strength Index (14 RSI): | 27.84 | Sell |
Chaikin Money Flow: | -1898565 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.46 - 16.9) | Sell |
Bollinger Bands (100): | (16.52 - 20.66) | Sell |
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3 | Sell |
Relative Strength Index (14 RSI): | 38.3 | Sell |
Chaikin Money Flow: | -1512628 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (453.88 - 474.62) | Sell |
Bollinger Bands (100): | (460.59 - 488.19) | Sell |
SNDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.1 | Sell |
20-day SMA: | 15.55 | Sell |
50-day SMA: | 17.53 | Sell |
200-day SMA: | 20.14 | Sell |
8-day EMA: | 14.18 | Sell |
20-day EMA: | 15.37 | Sell |
50-day EMA: | 16.93 | Sell |
200-day EMA: | 19.14 | Sell |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 465.52 | Sell |
20-day SMA: | 462.35 | Sell |
50-day SMA: | 473 | Sell |
200-day SMA: | 457.37 | Sell |
8-day EMA: | 462.47 | Sell |
20-day EMA: | 465.38 | Sell |
50-day EMA: | 469.55 | Sell |
200-day EMA: | 454.48 | Sell |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $1.44 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.25 per share.
Syndax Pharmaceuticals Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vertex Pharmaceuticals Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |